Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-01-30

FDA Approved: DEXILANT — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved Dexilant (dexlansoprazole) under an original application for the treatment of gastroesophageal reflux disease, including healing of erosive esophag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexilant (dexlansoprazole)

Snippet

ORIG AP for DEXILANT (DEXLANSOPRAZOLE)